维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Small BI"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
2	Biology and clinical development of vascularendothelial growth factor-targeted therapy in renal cell carcinoma显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
3	A pilot trial ofCTLA-4 blockade with human anti-CTLA-4 in patientswith hormone-refractory prostate cancer 显示文摘	Small EJ Tchekmedyian NS Rini BI	2007	Clin CancerRes2007，13，6：	1
4	Biology and clinical development of vascular en- dothelial growth factor--targeted therapy in renal cell carcinoma显示文摘	Rini BI Small EJ	2005	j Clin Oncol2005，23，5：	1
5	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma显示文摘	Rini BI Small EJ	2005	Clin Oncol2005，23，21：	1
6	Practice and progress in kidney cancer: Methodology for novel drug development 显示文摘	Rini BI Weinberg V Small EJ	2004	J Urol2004，171，61：	1
7	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
8	A pilot trial of CTLA-4 blockade with human anti-CLTA-4 in patients with hormone-refractory prostate cancer显示文摘	Small EJ Tchekmedyian NS Rini BI Fong L Lowy I Allison JP	2007	Clin Cancer Res2007，13，6：	1
9	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma 显示文摘	Rini BI Small EJ	2005	J Clin Oneol2005，23，5：	1
10	Signatures of polycomb repression and reduced H3K4 trimethylation are associated with pl5INK4b DNA methylation in AML 显示文摘	PAUL T A BIES J SMALL D	2010	Blood2010，115，：	1
11	Practice and progress in kidney cancer: methodology for novel drug development显示文摘	Rini BI Weinberg V Small EJ	2004	J Urol2004，171，61：	1
12	Practice and progress in kidney cancer: methodology for novel drug development 显示文摘	Rini BI Weinberg V Small EJ	2004	J Urol2004，171，61：	1
13	Is APOE-epsilon 4 a risk factor for congnitive impairment in normal aging? 显示文摘	Small BI Graves AB McEvoy CI	2000	Neurology2000，54，11：	1
14	A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer显示文摘	Small EJ Tchekmedyian NS Rini BI	2007	Clin Cancer Res2007，13，6：	1
15	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal ceil carcinoma显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
16	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma 显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
17	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma 显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1
18	A pilot trial of CT- LA-4 blockade with human anti - CTLA-4 in paticntswith hormonerefractory prostate cancer 显示文摘	Small EJ Tchekmedyian NS Rini BI	2007	Clin Cancer Res2007，13，6：	1
19	The potential for prostate cancer immunothera- py 显示文摘	Rini BI Small EJ	2003	Crit Rev Oncol Hematol2003，27，46：	1
20	Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma 显示文摘	Rini BI Small EJ	2005	J Clin Oncol2005，23，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示